Standard BioTools Inc. Interest Expense
Standard BioTools Inc. (LAB) reported Interest Expense of $4.57 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-01.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-03-01
- Standard BioTools Inc. interest expense for the quarter ending 2023-12-31 was $1.10M, a 7.73% decline year-over-year.
- Standard BioTools Inc. interest expense for the quarter ending 2023-09-30 was $1.22M, a 16.59% increase year-over-year.
- Standard BioTools Inc. interest expense for the quarter ending 2023-06-30 was $1.13M, a 6.31% increase year-over-year.
- Standard BioTools Inc. interest expense for the quarter ending 2023-03-31 was $1.12M, a 8.45% increase year-over-year.
- Standard BioTools Inc. interest expense for fiscal 2023 was $4.57M, a 5.45% increase from fiscal 2022.
- Standard BioTools Inc. interest expense for fiscal 2022 was $4.33M, a 13.29% increase from fiscal 2021.
- Standard BioTools Inc. interest expense for fiscal 2021 was $3.82M, a 7.03% increase from fiscal 2020.
- Standard BioTools Inc. interest expense for fiscal 2020 was $3.57M, a 16.52% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $2.32M derived: sum of 2 quarters · filed 2024-03-01 | $3.45M derived: sum of 3 quarters · filed 2024-03-01 | $4.57M 10-K · filed 2024-03-01 |
| 2023-09-30 | $1.22M 10-Q · filed 2023-11-07 | $2.35M derived: sum of 2 quarters · filed 2023-11-07 | $3.47M 10-Q · filed 2023-11-07 | $4.66M derived: sum of 4 quarters · filed 2024-03-01 |
| 2023-06-30 | $1.13M 10-Q · filed 2023-08-08 | $2.25M 10-Q · filed 2023-08-08 | $3.44M derived: sum of 3 quarters · filed 2024-03-01 | $4.49M derived: sum of 4 quarters · filed 2024-03-01 |
| 2023-03-31 | $1.12M 10-Q · filed 2023-05-09 | $2.31M derived: sum of 2 quarters · filed 2024-03-01 | $3.36M derived: sum of 3 quarters · filed 2024-03-01 | $4.42M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $2.24M derived: sum of 2 quarters · filed 2024-03-01 | $3.30M derived: sum of 3 quarters · filed 2024-03-01 | $4.33M 10-K · filed 2024-03-01 |
| 2022-09-30 | $1.05M 10-Q · filed 2023-11-07 | $2.11M derived: sum of 2 quarters · filed 2023-11-07 | $3.14M 10-Q · filed 2023-11-07 | $4.21M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $1.06M 10-Q · filed 2023-08-08 | $2.09M 10-Q · filed 2023-08-08 | $3.16M derived: sum of 3 quarters · filed 2023-08-08 | $4.13M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.03M 10-Q · filed 2023-05-09 | $2.10M derived: sum of 2 quarters · filed 2023-05-09 | $3.07M derived: sum of 3 quarters · filed 2023-05-09 | $3.97M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $2.04M derived: sum of 2 quarters · filed 2023-03-14 | $2.94M derived: sum of 3 quarters · filed 2023-03-14 | $3.82M 10-K · filed 2023-03-14 |
| 2021-09-30 | $968.00K 10-Q · filed 2022-11-09 | $1.86M derived: sum of 2 quarters · filed 2022-11-09 | $2.75M 10-Q · filed 2022-11-09 | $3.64M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $896.00K 10-Q · filed 2022-08-09 | $1.78M 10-Q · filed 2022-08-09 | $2.67M derived: sum of 3 quarters · filed 2022-08-09 | $3.56M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $887.00K 10-Q · filed 2022-05-09 | $1.78M derived: sum of 2 quarters · filed 2022-05-09 | $2.66M derived: sum of 3 quarters · filed 2022-05-09 | $3.56M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $890.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $1.77M derived: sum of 2 quarters · filed 2022-03-08 | $2.67M derived: sum of 3 quarters · filed 2022-03-08 | $3.57M 10-K · filed 2022-03-08 |
| 2020-09-30 | $885.00K 10-Q · filed 2021-11-09 | $1.78M derived: sum of 2 quarters · filed 2021-11-09 | $2.68M 10-Q · filed 2021-11-09 | $3.33M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | $897.00K 10-Q · filed 2021-08-06 | $1.80M 10-Q · filed 2021-08-06 | $2.44M derived: sum of 3 quarters · filed 2022-03-08 | $2.88M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | $900.00K 10-Q · filed 2021-05-07 | $1.54M derived: sum of 2 quarters · filed 2022-03-08 | $1.99M derived: sum of 3 quarters · filed 2022-03-08 | $2.48M derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | $643.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $1.09M derived: sum of 2 quarters · filed 2022-03-08 | $1.58M derived: sum of 3 quarters · filed 2022-03-08 | $4.28M 10-K · filed 2022-03-08 |
| 2019-09-30 | $444.00K 10-Q · filed 2020-11-09 | $935.00K derived: sum of 2 quarters · filed 2020-11-09 | $3.64M 10-Q · filed 2020-11-09 | $7.71M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $491.00K 10-Q · filed 2020-08-07 | $3.19M 10-Q · filed 2020-08-07 | $7.26M derived: sum of 3 quarters · filed 2021-02-25 | $11.28M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $2.70M 10-Q · filed 2020-05-11 | $6.77M derived: sum of 2 quarters · filed 2021-02-25 | $10.79M derived: sum of 3 quarters · filed 2021-02-25 | $14.71M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $4.07M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $8.09M derived: sum of 2 quarters · filed 2021-02-25 | $12.00M derived: sum of 3 quarters · filed 2021-02-25 | $13.89M 10-K · filed 2021-02-25 |
| 2018-09-30 | $4.02M 10-Q · filed 2019-11-08 | $7.93M derived: sum of 2 quarters · filed 2019-11-08 | $9.82M 10-Q · filed 2019-11-08 | $11.28M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $3.92M 10-Q · filed 2019-08-07 | $5.80M 10-Q · filed 2019-08-07 | $7.26M derived: sum of 3 quarters · filed 2020-02-27 | $8.72M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $1.89M 10-Q · filed 2019-05-07 | $3.35M derived: sum of 2 quarters · filed 2020-02-27 | $4.80M derived: sum of 3 quarters · filed 2020-02-27 | $6.26M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $2.91M derived: sum of 2 quarters · filed 2020-02-27 | $4.37M derived: sum of 3 quarters · filed 2020-02-27 | $5.82M 10-K · filed 2020-02-27 |
| 2017-09-30 | $1.46M 10-Q · filed 2018-11-06 | $2.91M derived: sum of 2 quarters · filed 2018-11-06 | $4.37M 10-Q · filed 2018-11-06 | $5.83M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $1.46M 10-Q · filed 2018-08-08 | $2.91M 10-Q · filed 2018-08-08 | $4.37M derived: sum of 3 quarters · filed 2019-03-18 | $5.82M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | $1.46M 10-Q · filed 2018-05-08 | $2.91M derived: sum of 2 quarters · filed 2019-03-18 | $4.37M derived: sum of 3 quarters · filed 2019-03-18 | $5.82M derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $2.91M derived: sum of 2 quarters · filed 2019-03-18 | $4.37M derived: sum of 3 quarters · filed 2019-03-18 | $5.82M 10-K · filed 2019-03-18 |
| 2016-09-30 | $1.45M 10-Q · filed 2017-11-07 | $2.91M derived: sum of 2 quarters · filed 2017-11-07 | $4.36M 10-Q · filed 2017-11-07 | $5.81M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $1.45M 10-Q · filed 2017-08-08 | $2.91M 10-Q · filed 2017-08-08 | $4.36M derived: sum of 3 quarters · filed 2018-03-08 | $5.81M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $1.45M 10-Q · filed 2017-05-09 | $2.91M derived: sum of 2 quarters · filed 2018-03-08 | $4.36M derived: sum of 3 quarters · filed 2018-03-08 | $5.81M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $2.90M derived: sum of 2 quarters · filed 2018-03-08 | $4.36M derived: sum of 3 quarters · filed 2018-03-08 | $5.81M 10-K · filed 2018-03-08 |
| 2015-09-30 | $1.45M 10-Q · filed 2016-11-09 | $2.90M derived: sum of 2 quarters · filed 2016-11-09 | $4.36M 10-Q · filed 2016-11-09 | $5.80M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | $1.45M 10-Q · filed 2016-08-09 | $2.90M 10-Q · filed 2016-08-09 | $4.35M derived: sum of 3 quarters · filed 2017-03-03 | $5.81M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | $1.45M 10-Q · filed 2016-05-09 | $2.90M derived: sum of 2 quarters · filed 2017-03-03 | $4.36M derived: sum of 3 quarters · filed 2017-03-03 | $5.77M derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $2.90M derived: sum of 2 quarters · filed 2017-03-03 | $4.32M derived: sum of 3 quarters · filed 2017-03-03 | $5.34M 10-K · filed 2017-03-03 |
| 2014-09-30 | $1.45M 10-Q · filed 2015-11-09 | $2.87M derived: sum of 2 quarters · filed 2015-11-09 | $3.89M 10-Q · filed 2015-11-09 | $3.90M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $1.42M 10-Q · filed 2015-08-10 | $2.44M 10-Q · filed 2015-08-10 | $2.44M derived: sum of 3 quarters · filed 2016-02-29 | $2.44M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $1.03M 10-Q · filed 2015-05-11 | $1.03M derived: sum of 2 quarters · filed 2016-02-29 | $1.03M derived: sum of 3 quarters · filed 2016-02-29 | $1.03M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.00K derived: sum of 2 quarters · filed 2016-02-29 | $4.00K derived: sum of 3 quarters · filed 2016-02-29 | $14.00K 10-K · filed 2016-02-29 |
| 2013-09-30 | $1.00K 10-Q · filed 2014-11-06 | $3.00K derived: sum of 2 quarters · filed 2014-11-06 | $13.00K 10-Q · filed 2014-11-06 | $25.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $2.00K 10-Q · filed 2014-08-04 | $12.00K 10-Q · filed 2014-08-04 | $24.00K derived: sum of 3 quarters · filed 2015-02-26 | $131.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $10.00K 10-Q · filed 2014-05-12 | $22.00K derived: sum of 2 quarters · filed 2015-02-26 | $129.00K derived: sum of 3 quarters · filed 2015-02-26 | $331.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $119.00K derived: sum of 2 quarters · filed 2015-02-26 | $321.00K derived: sum of 3 quarters · filed 2015-02-26 | $628.00K 10-K · filed 2015-02-26 |
| 2012-09-30 | $107.00K 10-Q · filed 2013-11-07 | $309.00K derived: sum of 2 quarters · filed 2013-11-07 | $616.00K 10-Q · filed 2013-11-07 | $1.01M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-06-30 | $202.00K 10-Q · filed 2013-08-07 | $509.00K 10-Q · filed 2013-08-07 | $899.00K derived: sum of 3 quarters · filed 2014-03-12 | $1.34M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-03-31 | $307.00K 10-Q · filed 2013-05-09 | $697.00K derived: sum of 2 quarters · filed 2014-03-12 | $1.14M derived: sum of 3 quarters · filed 2014-03-12 | $1.65M derived: sum of 4 quarters · filed 2014-03-12 |
| 2011-12-31 | $390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $829.00K derived: sum of 2 quarters · filed 2014-03-12 | $1.34M derived: sum of 3 quarters · filed 2014-03-12 | $3.10M 10-K · filed 2014-03-12 |
| 2011-09-30 | $439.00K 10-Q · filed 2012-11-09 | $951.00K derived: sum of 2 quarters · filed 2012-11-09 | $2.71M 10-Q · filed 2012-11-09 | $3.25M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | $512.00K 10-Q · filed 2012-08-14 | $2.27M 10-Q · filed 2012-08-14 | $2.81M derived: sum of 3 quarters · filed 2013-03-12 | $3.35M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | $1.76M 10-Q · filed 2012-05-15 | $2.30M derived: sum of 2 quarters · filed 2013-03-12 | $2.84M derived: sum of 3 quarters · filed 2013-03-12 | $3.39M derived: sum of 4 quarters · filed 2013-03-12 |
| 2010-12-31 | $538.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $1.08M derived: sum of 2 quarters · filed 2013-03-12 | $1.63M derived: sum of 3 quarters · filed 2013-03-12 | $2.16M 10-K · filed 2013-03-12 |
| 2010-09-30 | $540.00K 10-Q · filed 2011-11-14 | $1.09M derived: sum of 2 quarters · filed 2011-11-14 | $1.62M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $555.00K 10-Q · filed 2011-08-09 | $1.08M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $2.88M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |